$0.32
+0.00%Oct 30, 2026, 13:00 UTC
Alps Group Inc shareholders approved the adoption of its Second Amended and Restated Memorandum and Articles of Association.
Source:Oct 30, 2026, 13:00 UTC
Alps Group Inc shareholders approved an increase in the company’s authorized share capital.
Source:Oct 30, 2026, 13:00 UTC
Alps Group Inc shareholders approved a one-for-five consolidation of the company’s ordinary and preferred shares.
Source:Aug 7, 2026, 12:00 UTC
Alps Group Inc reported fiscal year 2026 financial results with revenue growing 44% to $4.9 million, driven by growth across cellular therapy, medical testing, laboratory, aesthetics beauty services, and healthcare products.
Source:Jul 13, 2026, 18:15 UTC
Tecnam proposes to launch a new regional airline under its Altair subsidiary to operate P2012 Traveller aircraft for regional air mobility services in Italy.
Source:Jun 9, 2026, 12:05 UTC
Alps Group Inc's subsidiary MyGenome received accreditation for its Whole Genome Sequencing under MS ISO 15189:2022.